Psoriatic Arthritis
Conference Coverage
EADV: New long-term data on biologics for pediatric psoriasis ‘encouraging’
The 1- and 5-year outcomes for adalimumab and etanercept in pediatric psoriasis are reassuring.
Conference Coverage
EADV: Pediatric psoriasis called ‘grossly undertreated’
Most dermatologists are reluctant to use systemic therapies for moderate to severe pediatric psoriasis, but study investigators say this is not...
Conference Coverage
ACR: Cardiovascular risk factors in psoriatic diseases are common, often go untreated
Key clinical point: Patients with psoriatic diseases have high rates of modifiable cardiovascular risk factors that often go untreated, based on...
Conference Coverage
State laws, regulatory concerns complicate biosimilars landscape
Conference Coverage
VIDEO: Psoriasis, psoriatic arthritis improve with bariatric surgery
Conference Coverage
Shingles vaccine protection lasted 5-6 years in autoimmune disease patients
Key clinical point: Protection against shingles appeared to wane between the fifth and sixth years after patients with autoimmune diseases...
Conference Coverage
Stroke risk rose in autoimmune disease patients after herpes zoster
Key clinical point: Stroke risk increased by 50% in the month after patients with autoimmune diseases had an episode of herpes zoster. Major...
Conference Coverage
Can bariatric surgery ease psoriasis too?
Bariatric surgery in obese patients may lessen the symptoms of psoriasis and psoriatic arthritis.
Conference Coverage
EADV: No cancer signal with ixekizumab
To date, ixekizumab doesn’t raise any malignancy concerns in studies in psoriasis patients.
Conference Coverage
EADV: Secukinumab shows sustained high efficacy in SCULPTURE through 3 years
Key clinical point: Three-year data from a phase III trial provide reassurance regarding the long-term safety and efficacy of secukinumab for...
Conference Coverage
EADV: Spotlight on alexithymia in psoriasis
Key clinical point: Alexithymia is strikingly common among psoriasis patients and is associated with multiple psychiatric comorbidities and...